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DISSERTATION ORGANIZATION 
 
This thesis is organized into five chapters. Chapter 1 is a general 
introduction providing literature review on the regulation of gene expression, 
processing-bodies (P-bodies), protein arginine methylation and Scd6 protein 
followed by overall objectives of this study. In chapter 2, the materials and 
methods used in this study are presented. Chapter 3 is the results of this study. In 
chapter 4, the present data and future directions are discussed. Chapter 5 provides 
general conclusions. 
  
 
 
 
CHAPTER 1 
 
GENERAL INTRODUCTION 
  
1.1 Literature review 
1.1.1 Messenger RNA quality control 
(a) An overview of gene control 
Thousands of DNA sequences contain the information to synthesize 
proteins, which dictate cell function. Different cell types express different set of 
genes. On the other hand, cells can change the fraction of expressed genes in 
response to environmental stimuli. There are many steps in the flow of 
information from DNA to RNA to protein. Thus a cell can regulate a gene 
expression at different levels: (1) when and how often a gene is transcribed into 
RNA (transcriptional control), (2) the splicing and processing of nuclear RNA 
are controlled (RNA processing control), (3) determining which 
processed-mRNAs are transported from nucleus to cytoplasm and where mRNAs 
locate in the cytoplasm (RNA transport and localization control), (4) controlling 
which mRNAs are translated to proteins (translational control), (5) steady state 
mRNA levels in cytoplasm are determined by mRNA decay control (mRNA 
degradation control), (6) the functional capabilities of the proteins are regulated 
(protein activity control) (Figure 1) (1). 
 
  
 
 
Figure 1. Gene expression can be controlled at different levels. 
 
Messenger ribonucleoprotein (mRNP) complexes, comprising transcripts 
and RNA-binding proteins (RBPs), regulate gene expression. The lifecycle of 
mRNP complex also begins with mRNA transcription and stretches to mRNA 
degradation. The ensuing gene regulatory mechanisms have been clarified by the 
analyses of compositions and kinetics of mRNP complexes at each of these steps 
(2).  
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of mRNAs, is an essential step in the mRNP lifecycle to set the steady state 
levels of mRNA expression and to respond rapidly to environment changes. In 
Saccharomyces cerevisiae (S. cerevisiae), cytoplasmic RNA turnover is regulated 
by two main pathways: (i) decapping by Dcp1/Dcp2 decapping complex 
followed by 5´-3´ degradation by exonuclease Xrn1 and (ii) 3´-5´ degradation by 
exosome complex. Both of these pathways follows the deadenylation by 
Pan2/Pan3 complex and/or Ccr4/Not complex (Figure 2) (3–6). 
 
 
 
Figure 2. General mRNA decay pathways 
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(c) Decapping and translation repression 
Previous studies have suggested that mRNA decay, which modulated by 
decapping complex, is the predominant pathway of mRNA degradation. Deletion 
of decapping enzyme led to slow growth or lethality in some strain backgrounds 
(7, 8). In yeast, mRNA decapping is carried out through a complex of the 
Dcp1/Dcp2 proteins-decapping enzymes, and several decapping activators. The 
core set of decapping activators includes Edc1, Edc2, Edc3, Pat1, Dhh1, the 
Lsm1-7 complex, and Scd6, all of which are conserved proteins in eukaryotes 
(9–12). Decapping activators promote the formation of decapping complex and 
stimulate removal cap structure by decapping enzymes (9, 13). An important 
issue of future research is study how these decapping activators are activated to 
be functional through how is their interaction network.  
All of these factors may not associate and function at the same time. 
Individual factors activate decapping process in different manners as follows. 
The cap structure is also involved in promoting translation by recruiting 
eIF4E/eIF4G translation initiation complex to the 5´ end of mRNA. Therefore, 
the first step of mRNA decapping process is the loss of cap-binding eIF4E/eIF4G 
complex from mRNA. Several studies have shown that competition exists 
  
between translation initiation and decapping. Replacing the translation initiation 
factors by decapping enzymes requires mRBPs referred to as decapping 
activators. Several decapping activators were indentified to repress translation 
initiation, thereby enhance decapping process such as Dhh1, Scd6, Stm1, Pat1 
(14–17). In particular, dhh1 pat1 double mutant showed the defect in mRNA 
decapping and was unable to repress translation in response to glucose 
deprivation - overexpression of Dhh1 or Pat1 led to translational repression (15). 
Pat1, Dhh1 and Scd6 were shown to block translation before the formation of 
48S pre-initiation complex (13), whereas Stm1 inhibited translation after the 
formation of 80S complex (14). Unresolved issue for these RBPs is how these 
components are remodeled to form decapping complex after releasing translation 
complex.  
1.1.2 Processing bodies 
Actively translating mRNPs associate with polysomes to initiate 
translation. Various stress conditions, such as glucose starvation and severe heat 
shock, induce phase transitions of these mRNPs toward the non-translating state 
and lead to the assembly of most mRNPs into cytoplasmic foci such as 
processing-bodies (P-bodies) and stress granules (SGs) (18). Although in both 
 	 
yeast and mammalian cells, P-bodies and SGs frequently overlap, they have 
distinct assembly dynamics and functions (Figure 3). Proteins required for active 
translation are found in SGs, whereas P-bodies include protein factors for mRNA 
decay machinery such as Dcp1/2, Dhh1, Edc3, and Scd6, suggesting functional 
diversity of these granules as sites of mRNA storage and mRNA degradation, 
respectively (Figure 3) (18). However, mRNA decay may occur without the 
formation of large P-bodies (19), and P-body core components have been 
co-localized with various molecules that are involved in biological processes 
such as DNA replication and PKA signaling (20, 21). Hence, knowledge of the 
activities of P-body components may clarify the physiological functions and 
kinetics of P-bodies. 
 
 
 
 
 
Figure 3. mRNP granules; P-bodies and stress granules 
 
P-body formation is induced by a variety of stress conditions and almost 
decapping activators such as Pat1, Dhh1, Edc3 and Lsm4 were recently identified 
as factors that promote the physical interactions between mRNPs required for PB 
assembly (22-25). However, it remains poorly understood which the signaling 
pathways mediating this assembly process. The cAMP-dependent protein kinase 
(PKA) negatively regulates P-body assembly process upon glucose starvation 
that is due, at least in part, to the direct phosphorylation of Pat1 (26). In contrast, 
the inactivation of the Target of Rapamycin Complex 1 (TORC1) and 
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AMP-activated protein kinase (AMPK) pathways do not affect the formation of 
P-body (27). Further studies are required to understand completely the regulation 
of P-body formation under various stress conditions.      
1.1.3 Non-histone protein arginine methylation 
Analysis of post-translational modifications (PTMs) of mRNP 
components such as arginine methylation elucidates the structures and functions 
of these gene expression regulators. It has been shown that the motif termed 
RGG box, that is rich in arginines and glycines, of several mRNP components 
influence numerous physiological processes such as transcription, pre-mRNA 
splicing, DNA damage signaling, mRNA translation and degradation (28). 
Previous study showed that protein containing the RGG boxes are common 
substrates of protein arginine methyltransferases (PRMTs) (29, 30). Arginine 
residues of RGG boxes can be monomethylated or dimethylated. Type I PRMTs 
(PRMT1-3, CARM1, PRMT6, PRMT8) catalyze the formation of 
monomethylarginines (MMAs) or asymmetric-dimethylarginines (aDMAs), 
whereas type II PRMTs (PRMT5, PRMT9) catalyze the formation of 
monomethylarginines (MMAs) or symmetric-dimethylarginines (sDMAs) 
(Figure 4A) (28, 30). Heterogeneous nuclear ribonucleoproteins (hnRNPs) 
  
containing N-terminal RNA-binding motifs in conjunction with RGG repeats are 
major substrates of PRMT1/Hmt1 in mammalian and yeast cells (31). Recently, 
arginine methylation has been shown to mediate RNA–protein, DNA–protein, 
and protein–protein interactions (32, 33). For instance, arginine methylation by 
PRMT1 is critical for the localization of the hRAP55A, Scd6 homologue in 
mammalian cells (Figure 4B) (34). 
In S. cerevisiae, Hmt1 was identified as the major type I PRMT (35). 
Although hmt1 single deletion did not affect cell viability, it showed cell lethality 
in genetic backgrounds lacking of cap-binding proteins or harboring npl3-1 allele 
(36, 37). Global analysis was carried out to understand the involvement of Hmt1 
in biological processes, and not only the substrate proteins but also the impact of 
arginine methylation on their functions were identified. Hmt1 methylates 
RGG/RG motifs of several RBPs such as Npl3 and Hrp1, thereby regulates their 
localization and function (Figure 4B) (38). Thus, Hmt1-mediated RGG/RG 
methylation can negatively or positively regulates protein activities (30, 39). 
An important question is whether the dynamic regulatory mechanisms 
based on the arginine methylation for non-histone proteins exist. Hmt1 
methyltransferase activity toward hnRNPs is regulated by environmental 
  
conditions. For example, rapamycin treatment or starvation leads to 
dephosphorylation of active phosphorylated Hmt1 (40). Moreover, it is also 
plausible that arginine demethylation reactions can reverse the methylation 
modifications (41). Recently, it was reported that purified human JmjC lysine 
demethylases (KDMs) could catalyze demethylation of both histon and 
non-histon synthetic methylated fragments (42).  
 
 
 
 
  
 
 
Figure 4. PRMTs methylate RGG/RG-containing proteins. (A) Arginine (Arg) 
methylation by PRMTs (Type I and Type II) generates monomethylarginine (Arg-MMA) and 
asymmetric dimethylarginine (Arg-aDMA), or symmetric dimethylarginine (Arg-sDMA). (B) 
RGG/RG- containing proteins, which are methylated by PRMTs/Hmts. 
 
1.1.4 Protein Scd6 
In S. cerevisiae, Scd6 was originally identified as a multicopy suppressor 
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of clathrin deficiency (43). Eukaryotic Scd6 family proteins include hRAP55 in 
human, mTral in mouse, xRAP55 in Xenopus laevis, Trailer Hitch (Tral) in 
Drosophila melanogaster (D. melanogaster), CAR-1 in Caenorhabditis elegans, 
Sum2p in Schizosaccharomyces pombe (44). Scd6 and its homologues are highly 
conserved, that contain N-terminal Lsm14 domains, serine/threonine 
(Ser/Thr)-rich regions, central FDF (phenylalanine-aspartate-phenylalanine) 
motifs and RGG (arginine–glycine–glycine) boxes (Figure 5A) (44). There are 
several predictions for the functions of Lsm14, Ser/Thr and FDF motifs in RNA 
metabolism but their actual functions remain to be determined. RGG repeats 
participate in the regulation of RNA-protein interactions, protein-protein 
interactions and protein localization (28). 
The biological function of Scd6 is not well established although it seems 
to repress translation initiation. Scd6 directly binds to eIF4G and inhibits the 
formation of 48S preinitiation complex in vitro (16). In S. pombe, Scd6 functions 
as a decapping activator, as indicated by the competition with Edc3 to induce 
decapping enzymes such as Dcp1/2 in vitro (12) (Figure 5B). Tral protein, the D. 
melanogaster homologue of Scd6 was shown to interact directly with the 
conserved RNA helicase DDX6, which is known as Dhh1 in budding yeast (45). 
  
However, in S. cerevisiae, details of the interaction of Scd6 with other decapping 
activators as well as the regulatory mechanisms for the functions and the 
locations remain to be determined to understand how this protein contribute in 
mRNA metabolism. 
1.2 Overall Objectives 
Scd6 is well known as a decapping activator and translation initiation 
repressor. However, it remains unknown whether Scd6 regulates general mRNA 
decapping or affects decapping of only a subset of mRNAs. The role of Scd6 in 
translation repression has not been confirmed in vivo. Although Scd6 localizes to 
P-bodies (Figure 5C), the precise dynamic and biochemical function of P-body 
localization remains to be studied. Moreover, it is restrained to analyze Scd6 
activities because scd6 deletion does not show any growth phenotype at normal 
growth condition. Aiming to understand unresolved issues of Scd6 physiological 
activities, one of the goals of this study was to identify promising interacting 
factors of Scd6 that would allow me to assign its functions. In addition, I aim to 
determine genetic and functional interactions of Scd6 with other decapping 
activators. 
  
 
 
Figure 5. Protein Scd6. (A) The domain architecture of Scd6. (B) Scd6 is a decapping 
activator. (C) Scd6 co-localizes with P-body marker, Dcp2. 
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CHAPTER 2 
 
MATERIALS AND METHODS 
 	 
2.1 Strains, plasmids, and general methods 
Escherichia coli DH5α was used for DNA manipulations. The present 
yeast strains and plasmids are described in Tables 1 and 2. Cells were grown in 
yeast extract-peptone dextrose (YPD), synthetic complete medium (SC), and 
synthetic minimal medium (SD), and in SC media lacking either amino acids or 
other nutrients (SC-Ura, SC lacking uracil). General procedures were performed 
as described previously in “Methods in yeast genetics” (46). 
 
 
Table 1. Yeast strains used in this study 
Name Genotype                                                                        
10B MATα ade2 trp1 can1 leu2 his3 ura3 GAL psi+ HOp-ADE2-HO 3' UTR 
10BD MATa/MATα ade2/ade2 trp1/trp1 can1/can1 leu2/leu2 his3/his3 ura3/ura3 
10BD-ds MATa/MATα ade2/ade2 trp1/trp1 can1/can1 leu2/leu2 his3/his3 ura3/ura3 
DHH1/dhh1∆::CgLEU2 SCD6/scd6∆::CgHIS3 
10BD-dsh MATa/MATα ade2/ade2 trp1/trp1 can1/can1 leu2/leu2 his3/his3 ura3/ura3 
DHH1/dhh1∆::CgLEU2 SCD6/scd6∆::CgHIS3 HMT1/hmt1∆::CgTRP1 
10BD-dse MATa/MATα ade2/ade2 trp1/trp1 can1/can1 leu2/leu2 his3/his3 ura3/ura3 
DHH1/dhh1∆::CgLEU2 SCD6/scd6∆::CgHIS3 EDC3/edc3∆::CgTRP1 
10BD-s MATa/MATα ade2/ade2 trp1/trp1 can1/can1 leu2/leu2 his3/his3 ura3/ura3 
SCD6/scd6∆::CgLEU2 
s-DCP2 MATa/MATα ade2/ade2 trp1/trp1 can1/can1 leu2/leu2 his3/his3 ura3/ura3 
SCD6/scd6∆::CgLEU2 DCP2/DCP2-GFP::HIS3 
d-DCP2 MATa/MATα ade2/ade2 trp1/trp1 can1/can1 leu2/leu2 his3/his3 ura3/ura3 
DHH1/dhh1∆::CgLEU2 DCP2/DCP2-GFP::HIS3 
ds-DCP2 MATa/MATα ade2/ade2 trp1/trp1 can1/can1 leu2/leu2 his3/his3 ura3/ura3 
DHH1/dhh1∆::CgLEU2 SCD6/scd6∆::CgHIS3 DCP2/DCP2-GFP::HIS3 
h-DCP2 MATa/MATα ade2/ade2 trp1/trp1 can1/can1 leu2/leu2 his3/his3 ura3/ura3 
HMT1/hmt1∆::CgHIS3 DCP2/DCP2-GFP::HIS3 
dh-DCP2 MATa/MATα ade2/ade2 trp1/trp1 can1/can1 leu2/leu2 his3/his3 ura3/ura3 
DHH1/dhh1∆::CgLEU2 HMT1/hmt1∆::CgHIS3 DCP2/DCP2-GFP::HIS3 
10BD-h MATa/MATα ade2/ade2 trp1/trp1 can1/can1 leu2/leu2 his3/his3 ura3/ura3 
HMT1/hmt1∆::CgHIS3 
h-S MATa/MATα ade2/ade2 trp1/trp1 can1/can1 leu2/leu2 his3/his3 ura3/ura3 
HMT1/hmt1∆::CgHIS3 SCD6/SCD6-mCherry::natNT2 
10BD-HMT1 MATa/MATα ade2/ade2 trp1/trp1 can1/can1 leu2/leu2 his3/his3 ura3/ura3 
HMT1/HMT1-13myc::kanMX6 
s-1 MATa ade2 trp1 can1 leu2 his3 ura3 scd6∆::CgLEU2 
10B-S MATα ade2 trp1 can1 leu2 his3 ura3 GAL psi+ HOp-ADE2-HO 3' UTR 
SCD6-mCherry::natNT2 
h-1 MATa ade2 trp1 can1 leu2 his3 ura3 hmt1∆::CgHIS3 
ds-1 MATa ade2 trp1 can1 leu2 his3 ura3 dhh1∆::CgLEU2 scd6∆::CgHIS3 
dsh-1 MATa ade2 trp1 can1 leu2 his3 ura3 dhh1∆::CgLEU2 scd6∆::CgHIS4 hmt1∆::CgHIS3 
10B-DCP2 MATα ade2 trp1 can1 leu2 his3 ura3 GAL psi+ HOp-ADE2-HO 3' UTR 
DCP2-GFP::HIS3 
s-DCP2-1 MATa ade2 trp1 can1 leu2 his3 ura3 scd6∆::CgLEU2 DCP2-GFP::HIS3 
d-DCP2-1 MATa ade2 trp1 can1 leu2 his3 ura3 dhh1∆::CgLEU2 DCP2-GFP::HIS3 
ds-DCP2-1 MATa ade2 trp1 can1 leu2 his3 ura3 dhh1∆::CgLEU2 scd6∆::CgLEU2 
DCP2-GFP::HIS3 
h-DCP2-1 MATa ade2 trp1 can1 leu2 his3 ura3 hmt1∆::CgHIS3 DCP2-GFP::HIS3  
dh-DCP2-1 MATa ade2 trp1 can1 leu2 his3 ura3 dhh1∆::CgLEU2 hmt1∆::CgHIS3 
DCP2-GFP::HIS3 
HMT1-1 MATα ade2 trp1 can1 leu2 his3 ura3 HMT1-13myc::kanMX6  
PJ69-4A MATa trp1-901 leu2-3, 112 ura3-52 his3-200 gal4D gal80D LYS2::GAL1-HIS3 
GAL2-ADE2 met2::GAL7-lacZ 
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Table 2. Plasmids used in this study 
Name Description                                             
YCplac33 URA3, CEN-ARS 
YCplac33-SCD6 URA3, CEN-ARS, SCD6 
YCplac33-SCD6RK URA3, CEN-ARS, SCD6RK 
YCplac33-SCD6RF URA3, CEN-ARS, SCD6RF 
YCplac33-SCD6FLAG URA3, CEN-ARS, SCD6FLAG 
YEplac195 URA3, 2µ 
YEplac195-SCD6 URA3, 2µ, SCD6 
YEplac195-SCD6FLAG URA3, 2µ, SCD6FLAG 
pGBD-c1 TRP1,2µ, ADH1pr-GAL4-BD 
pGBD-c1-SCD6 TRP1,2µ, ADH1pr-GAL4-BD-SCD6 
pGAD-c1 LEU2,2µ, ADH1pr-GAL4-AD 
pGAD-c1-HMT1 TRP1,2µ, ADH1pr-GAL4-AD-HMT1 
pCgLEU2 PCR template, C. glabrata LEU2 in pUC19 
pCgHIS3 PCR template, C. glabrata HIS3 in pUC19 
pCgTRP1 PCR template, C. glabrata TRP1 in pUC19 
pFA6a-13myc-kanMX6 PCR template, 13myc-ADH1t::kanMX6 
pRS314-EDC3-GFP TRP1, CEN-ARS, EDC3-GFP 
pRS316-SCD6-mRFP TRP1, CEN-ARS, SCD6RF-mRFP 
pRS316-SCD6RK-mRFP TRP1, CEN-ARS, SCD6RK-mRFP 
 
2.2 Gene deletion and protein tagging 
Gene disruption and insertion were performed using PCR-based gene 
replacement, as described previously (47, 48). 
2.3 Yeast two-hybrid assays 
PJ69-4A cells harboring pGBD-SCD6 were transformed with the yeast 
cDNA library pACT (49). Transformants were then plated on SC-Leu-Trp plates 
and incubated at 30˚C for 4 days. Plates were replica plated onto SC-Leu-Trp-His 
plates, SC-Leu-Trp-His plates containing 1-mM 3-aminotriazole (3-AT), and 
SC-Leu-Trp-Ade plates, and were incubated at 30˚C for 3 days. Twenty-three 
transformants showed the His+ Ade+ phenotype; corresponding library plasmids 
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were isolated from transformants, and were reassessed for interactions with Scd6. 
Insert DNAs were sequenced. 
To confirm the interactions of Scd6 and Hmt1 that were identified in 
two-hybrid screening analyses, pGAD-c1-Hmt1 was constructed and used as a 
prey vector. PJ69-4A cells were then co-transformed with pGBD-c1 or 
pGBD-c1-Scd6 with either pGAD-c1 or pGAD-c1-Hmt1. Transformants were 
spotted onto SC-Leu-Trp (WL), SC-Leu-Trp-His (WLH), and SC-Leu-Trp-His 
(WLH) plates containing 1 mM 3-AT and were then incubated for 3 days at 30˚C. 
2.4 Western blot analysis 
Samples were loaded onto SDS-PAGE or NU-PAGE gels and were then 
electroblotted onto ImmobilonTM polyvinylidene difluoride membranes (Merck 
Millipore, USA). Blots were blocked for 1 h at room temperature with TBS-M 
buffer containing 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 5% non-fat dry 
milk, and were then incubated with 1:1,000-diluted primary antibodies in TBS-M 
buffer overnight at 4˚C. After three final washes with TBS buffer containing 20 
mM Tris-HCl (pH 7.5) and 150 mM NaCl, blots were incubated with secondary 
antibodies, and were developed using enhanced chemiluminescence detection 
kits (Merck Millipore, USA). 
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2.5 Immunoprecipitation of Scd6Flag 
Cells were grown in SC-Ura medium at 30˚C to mid-log-phase and were 
harvested by centrifugation. The cells were then resuspended in XT buffer 
containing 50 mM HEPES-KOH, (pH 7.3), 20 mM potassium acetate, 2 mM 
EDTA, 0.1% Triton X-100, 5% glycerol protease inhibitors, 
phenylmethylsulfonyl fluoride (PMSF), aprotinin, and leupeptin. Glass beads 
were then added and cells were broken by rigorous vortexing at 4˚C (4 times at 
3,500 rpm for 30 s). Lysates were then centrifuged for 10 min at 15,000 g and 
supernatants were collected. Extracts were incubated with or without 200 µg/mL 
RNase A (Wako Pure Chemical Industries, Ltd., Japan) at room temperature for 
30 min prior to immunoprecipitation. 
To immunoprecipitate Scd6Flag, extracts were incubated with anti-Flag 
antibody coupled to protein G-Sepharose beads (Sigma Aldrich, USA) for 30 min 
at 4˚C. Scd6Flag-bound beads were then washed three times in XT buffer, and 
the bound material was eluted with elution buffer containing 0.1 mg/mL Flag 
peptide in XT buffer for 10 min at 4˚C. Samples were subjected to SDS-PAGE 
followed by colloidal Coomasie blue staining (Thermo Fisher Scientific). RNA 
was isolated from immunopreciptated samples using RNeasy Mini kit (Qiagen) 
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and subjected to UREA-PAGE followed by SYBR-Gold staining (Life 
Technologies). 
2.6 Protein purification and GST pull down assays 
GST- and His6- fusion proteins were purified from E. coli strain BL21 
(DE3) using glutathione-sepharose beads (GE) and Ni-NTA agarose beads 
(Novagen), respectively. GST- or GST-Scd6-bound beads were then resuspended 
in HB buffer containing PBS, 0.5% Tween20, 5 mM MgCl2, 5 mM 
2-mercaptoethanol, 1 mM PMSF, and a protease inhibitor cocktail (Complete 
EDTA-free, Sigma Aldrich, USA). His6-Hmt1 was then eluted from Ni-NTA 
agarose beads using a high concentration of imidazole. Proteins were dialyzed 
and concentrated using Amicon Ultra-2-30K (Merck Millipore Ltd.).  
His6-Hmt1 was incubated with either GST- or GST-Scd6 immobilized 
beads for 3 h at 4˚C. After washing 5 times with PBS, beads were boiled in SDS 
sample buffer and samples were then subjected to SDS-PAGE, followed by 
staining with Coomassie Brilliant Blue and immunoblotting with anti-His 
antibody (Sigma Aldrich, USA). 
2.7 Microscopy 
Cells were cultured until they reached an OD600 of approximately 0.6 in 
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appropriate SC medium. Cells were then collected, washed twice in fresh SC 
medium with or without 2% glucose, and were then resuspended in fresh SC 
medium with or without glucose followed by incubation at 30˚C for 20 min. 
Cells were harvested, washed again and immediately examined for granule 
formation using a Keyence BZ-X700 microscope (Keyence Corporation, Japan) 
at room temperature. Experiments were performed a minimum of three times. 
Fluorescence images were processed and analyzed for numbers of cells with foci 
formation and signal intensities. More than 200 cells were counted and 
percentages of cells with foci formation were calculated. Fluorescence intensities 
along 5-µm lines were measured using the linescan function in MetaMorph 
software (Molecular Devices, USA) and averages of more than 10 foci from each 
observation were fitted to a Gaussian distribution. 
2.8 Tandem mass spectrometry (arginine methylation mapping) 
Scd6Flag was immunopurified as described above and was then subjected 
to SDS-PAGE and stained using Colloidal Blue Staining Kits (Thermo Fisher 
Scientific, CA, USA). Gel bands containing Scd6Flag were excised and 
subjected to in-gel digestion with Chymotrypsin (Sequencing Grade, Promega). 
The resulting peptides were analyzed using a nanoflow LC-MS/MS system with 
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LTQ-Orbitrap hybrid mass spectrometer (model XL, Thermo Fisher Scientific, 
CA, USA) as described elsewhere (50) with some modifications. The peptide 
mixture was separated using reverse phase chromatography with a 0%–40% 
gradient of acetonitrile containing 0.1% formic acid over 80 min at a flow rate of 
100 nl/min using a Mightysil-RP-18 (3 µm particle, Kanto Chemical, Osaka, 
Japan) fritless column (45 mm × 0.150 mm i.d.). Eluted peptides were sprayed 
directly into a LTQ-Orbitrap hybrid mass spectrometer and raw data were 
acquired using Xcalibur version 2.0.7 (Thermo Fisher Scientific, USA) and were 
then converted to MGF files using Proteome Discoverer version 1.3 software 
(Thermo Fisher Scientific). Database searches were performed using MASCOT 
version 2.2.07 software and the Uniprot S. cerevisiae (strain ATCC 
204508/S288c) database with the following parameters: fixed modification, 
carbamidemethyl (Cys); variable modifications, oxidation (Met); maximum 
missed cleavages, 1; peptide mass tolerance, 20 ppm; MS/MS tolerance, 0.8 Da. 
Candidate peptides were selected with probability-based Mowse scores that 
exceed the threshold, indicating significant homology (p < 0.05; score over 20), 
and were referred to as “hits.” Precursor peptides containing dimethylarginine 
residues were detected according to mass increases of 28 Da from those of 
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unmodified precursor peptides. MS/MS spectra of dimethylated peptides were 
manually assigned, and side-chain fragmentation of methylated arginine peptides 
was detected as a neutral loss in MS/MS spectra to determine symmetric (31.04 
Da) or asymmetric (45.05 Da) dimethylarginine levels (34, 51). 
2.9 Polysome analysis 
Cells were grown until they reached an OD600 of approximately 0.8 and 
were harvested and resuspended in medium with or without glucose for 20 min. 
Cultures were washed once and resuspended in lysis buffer containing 80 
g/mL cycloheximide, 200 g/mL heparin, 10 mM Tris-HCl (pH 7.5), 0.1 M 
NaCl, 30 mM MgCl2, aprotinin and leupeptin. Glass beads were then added, and 
cells were broken by rigorous vortexing at 4˚C (4 times at 2000 rpm for 30 s). 
Lysates were then centrifuged for 10 min at 15,000 g and supernatants were 
collected. Sucrose gradients of 10%–50% were prepared in solutions containing 
1 mM DTT, 50 mM NH4Cl, 50 mM Tris-Acetate (pH 7.0), and 12 mM MgCl2 
using a Gradient Station (Biocomp Laboratories Inc.). Lysates were added to 
sucrose gradients and were centrifuged for 3 h at 27,000 rpm in a Beckman 
Coulter centrifuge (Optima L-100K) at 4˚C, followed by fractionation using an 
Incomparable Piston Gradient Fractionator and a Bio-miniUV monitor (Biocomp 
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Laboratories Inc.). OD254 values were monitored to represent fractionation 
results. 
2.10 Statistical analysis 
Data are presented as means ± standard deviations (SD) of at least three 
independent experiments. Statistical analyses were performed using student’s 
t-test or analysis of variance (ANOVA) followed by Tukey’s test and differences 
were considered significant when p < 0.05. 
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CHAPTER 3 
 
RESULTS 
 
 
3.1 Yeast two-hybrid screening for Scd6 interacting factors 
Scd6 is a translational repressor that reportedly interacts directly with 
eIF4G to block translation initiation (16). Scd6 is also known as a decapping 
activator that contributes to decapping complexes of Scd6, Edc3, Pat1, Dhh1 and 
decapping enzymes (13). To identify other sets of proteins that associate with 
Scd6 in cells, I performed yeast two-hybrid screening of yeast gDNA library 
using Scd6 as bait. DCP1 gene, which encodes a known Scd6-interacting partner, 
was recovered in this two-hybrid screening, confirming efficiency of my 
screening method. In addition, DNA fragments encoding other proteins such as 
Ebs1, Hmt1, Rps28a and Rps28b were recovered in this assay. Scd6-interacting 
candidates are listed in Table 3. 
Table 3. Result of Yeast two-hybrid screening assay 
Gene Description                                                              
HSE1 Subunit of the endosomal Vps27p-Hse1 complex 
GYP1 cis-Golgi GTPase-activating (GAP) protein for yeast Rabs 
RPS28A Protein component of the small (40S) ribosomal subunit 
RPS28B Protein component of the small (40S) ribosomal subunit 
ISF1 Serine rich, hydrophilic protein 
DCP1 Subunit of Dcp1p-Dcp2p decapping enzyme complex 
HMT1 Arginine methyltransferase 
EBS1 Protein involved in translation inhibition and nonsense-mediated decay 
UTP11 Subunit of U3-containing Small Subunit (SSU) processome complex 
HSP82 Hsp90 chaperone 
 
DNA fragment containing HMT1 was recovered as positive hit in my 
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screening. The interaction with Hmt1, an arginine methyltransferase, led me to 
analyze further as the interaction of Hmt1 and Scd6 might be an 
enzyme-substrate association. 
3.2 Scd6 directly interacts with Hmt1 
HMT1 was cloned from wild-type gDNA into pGAD-c1 vector and 
analyzed for interaction with GBD-Scd6. Cells expressing both GBD-Scd6 and 
GAD-Hmt1 exhibited the His+ phenotype, suggesting the interaction between 
Scd6 and Hmt1, confirming my 2-hybrid screening (Figure 6A).  
Hmt1 is the major type I protein arginine methyltransferase (PRMT) in 
budding yeast and catalyzes the production of both mono- and asymmetric 
methylarginines on histone and non-histone proteins, especially RNA-binding 
proteins, and thereby regulates the functions and localizations (30, 39). Several 
RNA-binding proteins require mRNAs to associate with other partners in the 
complex. Thus, to determine whether mRNA is required for the association of 
Scd6 and Hmt1 in vivo, I performed co-immunoprecipitation with or without 
RNase A treatment (Figure 6B). Immunoprecipitation of Scd6Flag from cell 
extracts with an anti-Flag antibody led to co-precipitation of Hmt1myc, as 
detected using an anti-Myc antibody in Western blots. I also found that Hmt1 
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immunoprecipitated with Scd6 regardless of RNase A treatment, suggesting that 
these proteins co-purify in an RNA-independent manner. Subsequently, I 
performed in vitro binding assays using recombinant proteins to determine 
whether this interaction is direct or not. In these experiments, His6-Hmt1 was 
significantly bound to GST-Scd6 (Figure 6C), indicating that the Hmt1–Scd6 
interaction is direct, and may be akin to enzyme and substrate interactions. 
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Figure 6. Scd6 interacts with Hmt1. (A) Two-hybrid analysis; the yeast strain PJ69-4A 
was co-transformed with pGBD-c1 or pGBD-c1-SCD6 with either pGAD-c1 or 
pGAD-c1-HMT1, colonies were spotted onto SC-Leu-Trp (WL) and SC-Leu-Trp-His (WLH) 
plates and incubated for 3 days at 30˚C. (B) Co-immunoprecipitation analysis; Scd6Flag was 
immunoprecipitated from Hmt1myc strains harboring YCplac33-SCD6FLAG or YCplac33 with 
an anti-Flag antibody, and probed for Scd6Flag and Hmt1myc using anti-Flag and anti-Myc 
antibodies. Similar experiments were performed using total extracts treated with RNase A prior 
to immunoprecipitation. (C) In vitro binding assays; His6-Hmt1 was incubated with Glutathione 
sepharose beads that had been preloaded with equal amounts of GST or GST-Scd6. 
Recombinant proteins were then detected using Coomassie staining and associated His6-Hmt1 
was detected using an anti-His antibody. 
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3.3 Scd6 contains asymmetrically methylated arginines in RGG motifs 
Interactions were observed between Hmt1 and Scd6 in yeast two-hybrid, 
co-IP, and in vitro binding assays, which suggested an enzyme–substrate 
interaction. PRMTs bind and methylate RGG repeats in numerous RNA-binding 
proteins, and Scd6 contains RGG repeats in its carboxy-terminus (16, 31). 
Accordingly, following immunoprecipitation of Scd6Flag from wild-type and 
hmt1 cell lysates using a monoclonal anti-Flag antibody, I found that the 
Scd6Flag band from hmt1 cells migrated slightly smaller than that of wild-type 
cells (Figure 7A), suggesting that bindings of Hmt1 may methylates Scd6. 
To confirm this possibility and determine whether modifications are 
present in Scd6, Scd6Flag from wild-type and hmt1 cells were immunopurified 
as described above and digested with chymotrypsin in gels. Collected peptides 
were then analyzed by tandem mass spectrometry. Those containing dimethyl 
arginine were compared. Chymotryptic peptides covering more than 80% of 
entire protein sequence of Scd6 were detected (Figure 7B). Among these, four 
peptides contained seven dimethyl arginines in RGG motifs of Scd6 from 
wild-type cells, but not from hmt1 cells (Figures 7B and C). Peptides containing 
aDMA or sDMA can be distinguished by neutral losses of dimethylamine (m/z 
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45.05) and monomethylamine (m/z 31.04), respectively (34, 51). Thus, I 
assigned spectra to the peptide 277–290, which has single aDMA and to the 
peptide 298–313, which has three aDMAs (Figure 8). 
  
 
 
Figure 7. Arginine residues in RGG motifs of Scd6 are dimethylated in 
Hmt1-dependent manner. (A) Scd6Flag proteins from wild-type and hmt1 cells were 
immunoprecipitated using an anti-Flag antibody and separated using NU-PAGE gels, and then 
visualized by immunoblotting with anti-Flag antibody. (B) Amino acid sequences of Scd6 are 
shown and chymotriptic peptides that identified using Tandem mass spectrometry analyses are 
indicated by underlines. Red letters indicate asymmetric dimethylarginines and residues of RGG 
motifs are shown in bold. (C) Chromatograms of four chymotryptic peptides of Scd6 containing 
asymmetric dimethylarginines were compared between wild-type (upper panel) and hmt1 cells 
(lower panel). Signal intensities of peptides were normalized to total ion current chromatograms 
and ratios of signal intensities of peptides between wild-type and hmt1 cells are presented as 
relative abundances of each peptide. NGSEVKDLSIL, an unmodified Scd6 peptide. 
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Figure 8. MS/MS spectra of identified peptides containing asymmetric 
dimethylarginines. the peptide 277–290 (GQASARPRFHSRG) and the peptide 298–313 
(RGNRGNRGRGGQRGNY). 
 
  
3.4 Hmt1 regulates subcellular localization of Scd6 
Previous studies have shown that Npl3 and Hrp1 are involved in the 
export of bulk mRNA from the nucleus and that Hmt1 is important for efficient 
export of these hnRNP complexes (38). Scd6 is a decapping activator and is 
accumulated in P-bodies under starvation conditions (16). Thus, I determined 
whether Scd6 localization is perturbed in hmt1 cells under conditions of glucose 
deprivation. Scd6 was chromosomally tagged with the red fluorescent protein 
mCherry in its C-terminus and colocalization with the P-body marker Edc3-GFP 
was observed in wild-type and hmt1 cells. Scd6-mCherry is functional because it 
rescued synthetic growth defect of scd6 dhh1 double mutant (data not shown). In 
wild-type cells, Scd6-mCherry foci were clearly observed upon glucose 
deprivation and colocalized well with Edc3-GFP. In contrast, disruption of 
HMT1 significantly decreased foci formation of Scd6-mCherry without affecting 
Edc3-GFP foci formation (Figures 9). These data suggest that Hmt1 is required 
for targeting of Scd6 to P-bodies under stress conditions.  
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Figure 9. Hmt1 affected Scd6 subcellular localization. (A) Localization of 
Scd6-mCherry and Edc3-GFP; Wild-type (WT) and hmt1 mutant cells carrying endogenous 
mCherry-tagged Scd6 were transformed with the pRS314-EDC3-GFP plasmid. Cells were then 
grown to mid-log phase and were resuspended in medium lacking glucose; Scale bar, 5 m. 
(B) Percentages of more than 200 cells with Scd6-mCherry or Edc3-GFP foci from three 
independent experiments are presented as means ± standard deviations (SD); *, P < 0.05.  
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3.5 Hmt1-dependent arginine methylation is involved in Scd6 subcellular 
localization 
Arginine methylation by PRMTs is implicated in nucleocytoplasmic 
shuttling of some hnRNPs (29), warranting further detailed analyses of the 
effects of arginine methylation on Scd6 dynamics in granules. Observed 
methylated arginine residues in Scd6 were substituted with lysine (methylation 
deficient, Scd6RK) or phenylalanine (methylation mimic, Scd6RF) (52), and 
were then visualized by tagging mRFP under glucose-deficient conditions. Under 
these conditions, the percentage of the cells with Scd6RK-mRFP foci was 
decreased in comparison with those with Scd6WT-mRFP foci, and this was 
consistent with the defects observed in hmt1 mutant cells (Figure 10). These 
results show that Hmt1-dependent arginine methylation within the RGG motifs 
of Scd6 is crucial for Scd6 accumulation in P-bodies under glucose-deprivation 
conditions. However, more severe defects of foci formation were observed with 
Scd6RF-mRFP indicating that this substitution may affect protein structure or 
associations of Scd6 with other components.  
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Figure 10. Subcellular localization of Scd6 proteins with mutations in the RGG 
motifs. (A) Substitutions of Scd6; Scd6RF, methylation-mimic substitution; Scd6RK, 
methylation-deficient substitution. (B) Scd6-mRFP localization; scd6 cells containing 
pRS316-SCD6-mRFP, pRS316-SCD6RF-mRFP, or pRS316-SCD6RK-mRFP were grown and 
observed as in A. (C) Percentages of more than 200 cells with Scd6-mRFP foci from three 
independent experiments are shown as means ± SD; *P < 0.05. 
 
A
B
Scd6 Scd6RF Scd6RK
ARPRFHSRGL GRGRGNYRGN RGNRGRGGQR 
ARPRFHSFGL GFGFGNYFGN FGNFGFGGQR 
281 291 301 310 
Scd6
Scd6RF
ARPRFHSKGL GKGKGNYKGN KGNKGKGGQR Scd6RK
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3.6 Scd6 is important for P-body formation 
Scd6 was identified as a core component of P-bodies, along with Dhh1, 
Dcp2, and Edc3 (13), and associations of these components are reportedly 
essential for P-body accumulation. Previous studies have shown that cells 
lacking Dhh1 have defective P-body formation (13). Although percentages of 
cells with Dcp2-foci in scd6 mutant cells under glucose starvation conditions did 
not differ from those of wild-type cells, signal intensities of these granules in 
scd6 cells were lower than those in wild-type cells (Figure 11). Detailed analyses 
of wild type cells using linescan showed that foci with strong signal intensities 
were successfully formed under glucose starvation conditions, but were 
significantly decreased in scd6 cells (P < 0.01, 0.68-fold). Additionally, Scd6 
overexpression induced multiple distinct signals for P-bodies without inducing 
stress (P < 0.01, 9.32-fold) compared to the cells with non-insert bearing vector 
(Figure 12). In contrast with a previous study (13), overexpression of SCD6 
using the 2-plasmid backbone did not lead to cell growth defect (data not 
shown). These results indicate that Scd6 plays important roles in the 
accumulation of P-bodies.  
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Figure 11. scd6 deletion impairs the accumulation of Dcp2-GFP foci. Foci formation 
of Dcp2-GFP under glucose depletion condition. Wild-type (WT) and scd6 mutant cells 
carrying endogenous Dcp2 tagged with GFP were grown to mid-log phase and were 
resuspended in medium lacking glucose (-Dex); Scale bar, 5 µm. Percentages of cells with 
Dcp2-GFP foci among more than 200 cells from three independent experiments are shown as 
means ± SD. Fluorescence intensities of Dcp2-GFP were measured using the linescan function 
in MetaMorph, and fluorescence profiles are shown in the right panel. 
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Figure 12. Overexpression of Scd6 induces the accumulation of Dcp2-GFP foci. Foci 
formation of Dcp2-GFP in Scd6–overexpression condition. Dcp2-GFP cells harboring 
YEplac195 (Empty) or YEplac195-SCD6 (2µ-SCD6) plasmids were grown to mid-log phase in 
glucose-containing medium (+Dex). Scale bar, 5 µm. Percentages of cells with Dcp2-GFP foci 
among more than 200 cells from three independent experiments are shown as means ± SD. 
Fluorescence intensities of Dcp2-GFP were measured using the linescan function in MetaMorph, 
and fluorescence profiles are shown in the right panel. 
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3.7 Arginine methylation is not involved in Scd6 function for P-body 
formation 
Under normal growth conditions, overexpression of methylation-mimic 
and -deficient Scd6 induced the formation of P-bodies to similar degrees as 
overexpressed wild-type Scd6 (Figures 13A and 13B). No detectable differences 
in foci formation of Edc3-GFP were observed in hmt1 mutant cells compared 
with that in wild-type cells under glucose starvation conditions (Figure 9A). Thus, 
my observations suggest that although arginine methylation of Scd6 by Hmt1 is 
essential for targeting of Scd6 to P-bodies, it is not required for cooperative 
contributions of Scd6 and Dhh1 to the formation of P-bodies under physiological 
and stressed conditions, such as glucose starvation. However, further studies are 
necessary to determine the involvement of methylation in the regulation of Scd6 
function following acute stress conditions such as heat shock. 
  
 
Figure 13. Scd6 function for P body formation is independent on arginine 
methylation. (A) scd6 Dcp2-GFP cells harboring YCplac33 (CEN) or YEplac195 (2µ) 
plasmids containing wild-type (SCD6), methylation-deficient (SCD6RK), or methylation-mimic 
(SCD6RF) substitutions were grown to mid-log phase in glucose-containing medium 
(+Glucose); Scale bar, 5 µm. (B) Percentages of Dcp2-GFP foci among more than 200 cells 
from three independent experiments are shown as means ± SD; *P < 0.05. 
A
B
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3.8 Scd6 has synthetic effects with Dhh1 on cell growth and P-body 
formation 
Analyses of Scd6 physiological functions in vivo were restrained because 
the scd6 mutation did not affect growth under normal conditions. Thus, I 
performed genetic analyses to investigate synthetic functions of Scd6 with 
components of decapping activators. Genetic interactions were identified 
between scd6 and dhh1 alleles. dhh1 scd6 double mutants showed synthetic 
growth defects compared with those observed in dhh1 single mutants at 25˚C 
(Figure 14A), and these growth defects became more severe at 37˚C (Figure 
14B), suggesting functional redundancies of Scd6 and Dhh1 for cell growth. 
As I and others have shown that both Scd6 and Dhh1 have function, in as 
much as some extent, for P-body formation (15), scd6 dhh1 double mutant 
showed almost complete defect for the formation of P-bodies under glucose 
starvation conditions (Figures 15). These data confirm the shared roles of Scd6 
and Dhh1 that were observed in in vivo experiments, including roles in P-body 
formation under stress conditions. 
 
  
  
 
Figure 14. scd6 dhh1 mutant strain showed synthetic growth defect. (A) Growth of 
scd6 dhh1 mutant strain; Heterozygous strains carrying mutations in dhh1 and scd6 alleles were 
sporulated, and tetrads were dissected onto YPD medium. Growth after 4 days at 25˚C is shown. 
(B) Growth assays; Wild-type (WT), scd6, dhh1, and scd6 dhh1 mutant cells were spotted onto 
YPD medium and incubated at 25˚C or 37˚C. 
 
 	 
 
 
Figure 15. Scd6 and Dhh1 have overlapping functions in P-body formation. (A) 
Dcp2-GFP foci formation; Wild-type (WT), scd6, dhh1, and scd6 dhh1 cells in which 
endogenous Dcp2 was tagged with GFP were grown in glucose-containing medium to the 
mid-log phase and were then resuspended in medium lacking glucose; Scale bar, 5 µm. (B) 
Percentages of more than 200 cells with Dcp2-GFP foci from three independent experiments are 
shown as means ± SD; **P < 0.01. 
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3.9 Scd6 is not a global translation repressor 
Previously, global translation repression and P-body formation were 
correlated under conditions of glucose deprivation (15). Accordingly, if Scd6 acts 
as a general translation repressor, defects in translation repression in scd6 dhh1 
double mutants are likely correlated with defects in P-body formation. As a 
model of global translational repression, glucose deprived cells exhibit declines 
in translation with polysome profiles (15, 17). In the present study, wild-type and 
scd6 dhh1 cells were cultured in glucose-containing medium until the mid-log 
phase and were then subjected to glucose deprivation prior to polysome analyses. 
Under glucose starvation conditions, scd6 dhh1 cells showed similar reductions 
in polysome fractions to those observed in wild-type cells (Figure 16), suggesting 
that overlapping cell growth and P-body formation functions of Scd6 and Dhh1 
may not be related to global translation repression.  
Polysome profiling was performed based on the same total RNA 
concentrations for all samples. dhh1 scd6 mutant has defect of growth, so the 
amount of deceased cells were present in polysome profiling was larger than 
wild-type. Therefore, polysome level decreased in scd6 dhh1 mutant comparing 
to wild-type cell, both in the media with and without glucose (Figure 16). 
  
 
 
 
Figure 16. Scd6 was not essential for general translation repression under glucose 
starvation conditions. Wild-type (WT) and scd6 dhh1 cells were grown in rich medium (+Dex) 
and were subjected to glucose deprivation (-Dex) and typical polysome profiles (OD254 traces) 
are presented. Small and large ribosomal subunits (40S and 60S, respectively), monosomes 
(80S), and polysomes are labeled. 
 
3.10 Arginine methylation regulates Scd6 function in relation to Dhh1 on cell 
growth  
Next, I investigated the relationship between Dhh1 and Hmt1. Tetrad 
analysis revealved that dhh1 single mutant grows slower than wild-type, and 
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dhh1 hmt1 double mutant grows much slower than dhh1 single mutant, and was 
similar to scd6 dhh1 mutant. hmt1, scd6 and scd6 hmt1 mutants showed normal 
cell growth phenotype (Figure 17). Thus, Hmt1 and Scd6 may similarly regulate 
Dhh1-mediated cell growth. 
To determined whether Hmt1-dependent arginine methylation of Scd6 is 
involved in Scd6 and Dhh1 mediated regulation of cell growth, I showed that 
expression of wild-type Scd6 recovered cell growth in scd6 dhh1 mutant cells at 
25˚C (Figure 18). Moreover, suppressive effects of Scd6 methylation-mimic and 
-deficient substitutions were indistinguishable from wild-type cells at 
physiological temperature. However, at 37˚C, both wild-type and 
methylation-deficient Scd6 suppressed cell growth, whereas methylation-mimic 
Scd6 did not. This result implicates that at elevated temperature loss of positive 
charge at arginine residues by substituting phenylalanine residues for arginine 
residues negatively regulates Scd6 function on cell growth; thereby arginine 
methylation probably leads to the same suppression.   
  
 
 
Figure 17. dhh1 hmt1 mutant strain showed synthetic growth defect. Growth of scd6 
hmt1 and dhh1 hmt1 mutant strains. Strains that were heterozygous for scd6 hmt1 and dhh1 
hmt1 were sporulated, and tetrads were dissected onto YPD medium. Growth was determined 
after 4 days at 25˚C.  
 
 
 
 
Figure 18. Positive charge at arginine residues is required for Scd6 function on cell 
growth at elevated temperature. Growth assays; scd6 dhh1 mutant cells harboring empty 
vector (empty) or plasmids containing wild-type, methylation-deficient (SCD6RK), or 
methylation-mimic (SCD6RF) substitutions were spotted onto YPD medium and incubated at 
25˚C or 37˚C.  
 
  
3.11 Scd6, Dhh1 and Edc3 have synthetic effect on cell growth 
Genetic interactions between scd6, dhh1 and edc3 alleles were examined. 
Both edc3 scd6 and dhh1 edc3 double mutants showed synthetic growth defects. 
The dhh edc3 scd6 triple mutant had more severe growth defect than those 
double mutants (Figure 19). This result indicated that these three decapping 
activators have combined impact on cell growth.  
Whereas dhh1 hmt1 double mutant showed synthetic growth defect, the 
same phenotype was not observed in edc3 hmt1 double mutant (data not shown). 
This result again suggested that at physiological growth condition, Hmt1-based 
arginine methylation is not required for Scd6 role for cell growth (Figure 18). 
 
  
 
 
Figure 19. dhh1 edc3 scd6 mutant strain showed synthetic growth defect. Growth of 
dhh1 edc3 scd6 mutant strains. Strains that were heterozygous for dhh1 edc3 scd6 were 
sporulated, and tetrads were dissected onto YPD medium. Growth was determined after 4 days 
of incubation at 25˚C.  
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CHAPTER 4 
 
DISCUSSION 
  
In the present study, I demonstrated the roles of Scd6 with Dhh1 and Edc3 
on cell growth. Further analysis of Dhh1 and Scd6 interaction revealed their 
shared functions for the formation of P-bodies and cell growth, particularly under 
stress conditions. In addition, Hmt1 associated with and methylated Scd6 leading 
to the efficient targeting of Scd6 to P-bodies. Arginine methylation of Scd6 
might negatively regulated Scd6 function on cell growth at elevated temperature 
(Figure 20). However, molecular details of these arginine methylation-based 
regulations remain to be addressed in future work. It is possible that arginine 
methylation is required for Scd6 to regulate its specific mRNA targets. There are 
increasing evidences that post-translational modifications affect RBPs functions. 
Likewise, arginine methylation in this study could offer a common mechanism 
for mRNP components to facilitate their dynamics in the cells.  
 
  
 
 
Figure 20. Proposed model of Scd6 physiological activities in this study 
 
4.1 Hmt1-based arginine methylation could be a reversible modification 
under environmental stimuli. 
Post-transcriptional regulation system and the dynamic of mRNP 
complexes have the fastest responses to a change of environment compared to 
other gene expression regulation steps. However, initial studies for the arginine 
methylation modification suggested that methyl groups were stable on arginine 
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residues (30). It remains to be determined that the extent to which arginine 
methylation is dynamic and whether protein arginine demethylation reactions 
occur to reverse the effects of the modifications. Recently, it has been shown that 
purified human JmjC lysine demethylases (JmjC KDMs) can also act as JmjC 
arginine demethylases (JmjC RDMs) both on histone and non-histone peptides, 
indicating arginine methylation may be a reversible modification (42). There 
were significant changes in arginine methylation abundance associated with 
growth conditions. Particularly, the concentrations of mono-methylarginines and 
asymmetric-dimethylarginines decreased during heat shock and stationary phase 
compared to log-phase growth, whereas symmetric-dimethylarginines increased 
(53). In the present study, under physiological growth condition (25˚C), 
substitutions of arginine that were identified to be methylated in Scd6 neither 
affected cell growth nor P-body formation (Figures 13 and 18). However, at 
elevated temperature (37˚C), suppression of synthetic growth defects in dhh1 
scd6 mutant cells was observed with wild-type and the methylation-deficient 
Scd6, but not with the methylation-mimic Scd6 (Figure 18). These observations 
suggest that stress-dependent regulation of Scd6 activities may be due to the 
dynamic change of Hmt1-mediated methylation. Future studies are needed to 
 
 
determine whether the methylation of Scd6 is reversible and how the 
modification is actively regulated upon environmental stimuli. Accordingly, it 
will be important to identify demethylases that catalyze non-histone arginine 
demethylation and to assess its biological significance. 
4.2 Hmt1 possibly mediate the effect of Scd6 on specific target mRNAs  
Previous studies suggest that arginine methylation of RNA-binding 
proteins by PRMTs can modulate binding affinities for RNAs– or protein–protein 
interactions of targets (30, 39). Compared to wild-type cells, we did not see 
significant changes in total Scd6Flag-associated proteins or total RNAs in hmt1 
cells (data not shown). Thus, arginine methylation of Scd6 may act on specific 
mRNA targets. However, there is currently limited information on subsets of 
mRNA targets that coupled to Scd6 accumulation to P-body or function toward 
cell growth. Therefore, one needs to indentify specific mRNA targets to validate 
these hypotheses. 
Depletion of HMT1 specifically resulted in defect of Scd6 localization 
whereas remarkable foci formation defects were not observed for other 
components of P-bodies such as Dcp2 and Edc3 (Figure 9). Scd6 overexpression 
promoted P-body formation independently of Hmt1-mediated arginine 
  
methylation (Figure 13). Therefore, a goal in future work will be to unveil the 
significance of arginine methylation by Hmt1 in targeting Scd6 to P-bodies. A set 
of Scd6-precipitated mRNAs was submitted to the Gene Expression Omnibus 
(GEO) by Dan Klass in 2010. These data show that mRNAs that are transcribed 
from sub-telomeric regions, coding mRNAs for proteins of telomere capping 
maintenance and replication stress response such as MEC1 and TEL1, were 
substantially accumulated in Scd6-precipitated samples. In addition, it has been 
shown that protein arginine methylation has roles in DNA repair under 
replication stress (32). These data suggest that Scd6 may specifically bind to and 
activates the mRNA decapping under replication stress condition. Arginine 
methylation on Scd6 could be required to target the complex of these mRNAs to 
the P-bodies, thereby keeping mRNAs stored rather than to degraded. 
4.3 Scd6 could have the functional connection to the biological processes that 
are regulated by Hmt1. 
Recent accumulating evidence indicates that analysis of Hmt1 
methyltransferase activity is fundamental to understand protein functions and 
various molecular processes. In particular, following interactions with Hmt1, 
Ccr4-Not complexe is involved in mRNA maturation and Npl3-dependent 
  
nuclear export, and likely participate in cell-cycle progression by stabilizing 
cyclin mRNA in response to environmental stimuli (40, 54). Previous data 
suggest that Scd6 is functionally involved in Hmt1-targets. For instance, Scd6 
and Npl3 played similar roles in the targeting of eIF4G for translation repression 
(16), and scd6 ccr4 mutant cells had more severe synthetic growth defects than 
ccr4 mutant cells (data not shown). Further studies could clarify the involvement 
of Scd6 in nuclear export of mRNA, and whether Hmt1 mediates the effects of 
Scd6 on cell cycle progression, as it does for Npl3 and Ccr4-Not. 
4.4 Arginine methyltransferases has functional and dynamic link with 
RGG-motif containing mRNP components 
P-body localization of Scd6 has been shown under conditions of glucose 
deprivation (16), and previous studies suggest that P-bodies contain multiple 
proteins of mRNA decay machinery (55). The present data show that Hmt1 binds 
and methylates Scd6. Hmt1 was previously shown to catalyze arginine 
methylation of mRNP components with RGG motifs such as Npl3, Sbp1, and 
Ded1, which are reportedly localized in RNA granules (30). In addition, the 
P-body component Ebs1 (56) was recovered in my two-hybrid analysis, also 
recovered in proteomic analysis of Hmt1-TAP associating proteins (57). These 
  
observations suggest the presence of a functional link between Hmt1 and 
components of P-bodies (58). Hmt1 and Scd6 interaction may facilitate the above 
consequences. 
Several arginine residues within the RGG motif of Scd6 were methylated 
in Hmt1 dependent manner. Moreover, our mass spectrometry analyses revealed 
the presence of DMAs in Scd6 peptides from wild-type cells, and these 
modifications were still observed in samples from hmt1 mutant cells (data not 
shown). Although Scd6 was not recovered in proteomic analyses using a 
methylarginine antibody, the present data indicates that Scd6 is hyper methylated 
by additional methyltransferase. Hence, future assessments of degrees of 
methylation and identification of responsible enzyme(s) may further reveal how 
arginine methylation could regulate the function of mRNP components. 
  
 
 
 
CHAPTER 5 
 
CONCLUSION 
  
The main objective of this study was to analyze the physiological 
activities of Scd6: its localization, interactions, functions and regulatory 
mechanisms in RNA decay pathway. By investigating Scd6 interacting factors, I 
found that Scd6 interacts with Hmt1. In addition, I examined the roles of Scd6 
for P-body formation and its interactions with other decapping activators. 
First, by two-hybrid screening assay using Scd6 as bait, I found Scd6 
interacting candidates including known Scd6-interacting partner, Dcp1. In this 
study, I focused on analyzing the interaction with Hmt1, a mono- and 
asymmetric di-arginine methyltransferase. I found that Hmt1 directly binds to 
Scd6. Deletion of HMT1 results in loss of Scd6 methylation in the RGG motifs. 
This Hmt1-dependent methylation was involved in Scd6 subcellular localization 
under glucose starvation. In addition, I revealed that Scd6 plays a role with Dhh1 
and Edc3. Scd6 also gave synthetic impact on P-body formation with Dhh1. 
Although Scd6 is highly methylated in physiological condition that is required 
for its efficient targeting to P-bodies, this methylation is not required for Scd6 
function on cell growth at 25oC or overexpression-mediated induction of P-body 
formation. These results show that Scd6 accumulated to facilitate the P-body 
formation and arginine residues within the RGG motif were not strictly required 
  
for cell growth in dhh1 mutation background, at least under physiological 
condition. 
I show herein the regulation of Scd6 physiological activities by 
Hmt1-dependent arginine methylation. The present study provides a new insight 
into how post-translational modifications of mRNP components could regulate 
the gene expression in response to external conditions. 
  
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